| Fund | Type | Gross assets | Min. |
|---|---|---|---|
| Solas Bioventures Emerging Healthcare Fund, LP | Venture Capital | $51.9M | $1M |
| Solas Bioventures Fund II, LP | Venture Capital | $34.3M | $500K |
| Solas Francis Sidecar | Venture Capital | $24.5M | $25K |
| Name | Title | Ownership | Since |
|---|---|---|---|
| Charles David Adair Control | Manager | 50-75% | 2020 |
| David Alan Belitz | Manager | Under 5% | 2023 |
| Jared William Hollinger | Manager | Under 5% | 2024 |
Solas Bioventures Management, LLC reports $177.7 million in regulatory assets under management on its Form ADV.
Solas Bioventures Management, LLC manages 13 private funds with combined gross assets of $177.7 million.
Solas Bioventures Management, LLC reports 6 employees.
Solas Bioventures Management, LLC is based in Chattanooga, TN and has been SEC-registered since 2025.
Solas Bioventures Management, LLC is not required to publicly disclose fund returns. Form ADV filings include assets, ownership, and service providers, shown above.
| Address | 412 Georgia Avenue, Suite 201, Chattanooga, TN 37403 |
| Phone | 423-243-3460 |
| Office hours | 9:00a.m. - 5:00p.m. Eastern |
| SEC region | Atlanta Regional Office (ARO) |
| Umbrella registration | Yes |
| Discloses disciplinary history | No |
| Discretionary | $177.7M |
| Non-discretionary | $0 |
| Total (RAUM) | $177.7M |